Navigation Links
Ranbaxy Labs' Entry Into Anti-Acne Market

Ranbaxy Laboratories' entry into the global anti-acne market is likely to be delayed as the mandatory inspection by the US Food and Drug Administration (US FDA) for the company's ANDA (Abbreviated New Drug Application) for the generic isotretinoin has been postponed. The US FDAs investigator had not yet arrived.

The US FDA has already approved its manufacturing facility for the product. A special investigator for checking the manufacturing process has, however, not arrived as per schedule.// Ranbaxy had applied for Para III filing to get the nod for marketing the generic isotretinoin.

Pharma major Roche Laboratories holds the patent for the active ingredient and markets it under the brand, Accutane. Accutane is used in the treatment of severe recalcitrant nodular acne. One other large US generic company, Mylan, is also expected to be in the race to manufacture and market the drug. The patent for isotretinoin will expire in February 2002. The worldwide sales of Accutane are about $757 million and are growing at about 8% - 10% .

The US FDA has been quite stringent in its inspections for the anti-acne drug to check for possible side effects. The drug is suspected to have side effects, particularly depression. Hence, the US FDA is expected to be quite rigid in granting approvals for this generic drug.
'"/>




Page: 1

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Ranbaxy gets US FDA approval for Lisinopril
3. Ranbaxy trying to make inroads in herbal drugs market
4. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
5. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
6. Ranbaxy opens Drug discovery centre in Gurgaon
7. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
8. SRL Ranbaxy offers quicker bird flu diagnostic test
9. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
10. Ranbaxy Launches Once-a-day Inhaler For Asthma Patients
11. Ranbaxy Expands By Acquiring A Generic Company In Belgium
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... , ... CURE Media Group, the nation’s leading digital and print media enterprise ... Cancer in efforts to combat lung cancer, announced CURE Media Group President Michael J. ... Group is honored to team up with Upstage Lung Cancer in order to make ...
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and The Chopra Center ... loss and wellness program, at their world headquarters of Omni La Costa Resort & ... results to anyone seeking weight loss, personal development, a healthy lifestyle, or mental and ...
(Date:12/8/2016)... ... 08, 2016 , ... Catalent Pharma Solutions, the leading global ... health products, today announced that it had joined the Pharmaceutical Supply Chain Initiative ... to unite pharmaceutical and healthcare companies that share a vision of better, social, ...
(Date:12/8/2016)... ... ... California Senate Bill (SB) 863, signed into law in 2012, may have ... according to CompScope™ Medical Benchmarks for California, 17th Edition , a study by ... payments per claim in California decreased 4 percent in 2013 and then 3 percent ...
(Date:12/8/2016)... Francisco, California (PRWEB) , ... December 08, 2016 , ... ... coaches, has raised an $18M Series B led by Canvas Ventures . Other ... the capital to scale its mobile platform to serve more consumers who are managing ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Texas , Dec. 8, 2016 ... program that brings leading-edge laboratory services and management ... United States , allowing more doctors and ... health care management solutions. Logo - ... Hospital systems, under pressure to contain ...
(Date:12/8/2016)... , Dec. 8, 2016 A Small ... the National Institutes of Health (NIH) to ... University.  The grant will seek to ... head device, which utilizes electromagnetic waves to treat Alzheimer,s ... this novel technology to possibly treat other neurologic disorders ...
(Date:12/8/2016)... , Dec. 8, 2016  Boehringer Ingelheim announced ... Corporate Equality Index (CEI). This is the ninth time ... been designated as a Best Place to Work for ... the CEI is a national benchmarking report on corporate ... gay, bisexual and transgender (LGBT) employees. ...
Breaking Medicine Technology: